Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology

Leihong Wu, Yi Wang, Zheng Li, Boli Zhang, Yiyu Cheng, Xiaohui FanChinese 2014 · DOI

TL;DR

This study introduces a novel network pharmacology approach, the Network Recovery Index for Organism Disturbed Network (NRI-ODN), to analyze the synergistic effects of traditional Chinese medicine (TCM) formulas. By modeling the complex molecular interactions in acute myocardial ischemia (AMI), they demonstrate how the QiShenYiQi (QSYQ) formula, adhering to the "Jun-Chen-Zuo-Shi" principle, effectively restores disturbed biological networks, highlighting the distinct roles of its component herbs.

What Problem Does This Paper Address?

Traditional Chinese Medicine (TCM) is characterized by its complex formulations involving multiple ingredients acting on multiple targets. Understanding the precise pharmacological roles of individual herbs within a formula, especially in relation to established TCM principles like "Jun-Chen-Zuo-Shi" (sovereign-minister-assistant-courier), remains a significant challenge. This principle suggests a hierarchical contribution of herbs to a formula's efficacy. While QSYQ has shown clinical promise in treating acute myocardial ischemia (AMI), the molecular mechanisms underlying its efficacy and the specific contributions of its constituent herbs, particularly through the lens of the "Jun-Chen-Zuo-Shi" rule, have not been fully elucidated. This paper aims to bridge this gap by developing and applying a network pharmacology approach to dissect these complex interactions.

Methods

The core of this study is the development of a network pharmacology framework to analyze AMI. This involved:

  • Constructing an Organism Disturbed Network (ODN): An AMI-specific ODN was built by integrating data on disease-associated genes (from CHD@ZJU and RGD databases), protein-protein interaction (PPI) data (from HPRD and BioGRID), and gene expression data from microarray experiments. This network represents the molecular landscape of AMI.
  • Developing the Network Recovery Index (NRI-ODN): A novel quantitative index, NRI-ODN, was created to measure the therapeutic efficacy of TCM formulas and their components. It assesses the ability of a drug or herb to "recover" the disturbed AMI network back to a normal state. This index considers both the regulation level of genes and, in a refined version, their topological importance within the network.
  • Identifying Efficient Recovery Genes (ERGs): Genes that showed a significant recovery effect (defined by an Efficiency of Recovery Regulation, EoR, of >50%) were identified.
  • Pathway Enrichment Analysis: KEGG pathway database was used to identify biological pathways significantly enriched by the ERGs, providing insights into the functional mechanisms of the formula and its components.

Datasets

The study utilized the following datasets:

  • Disease-associated genes: CHD@ZJU (coronary heart disease related genes) and Rat Genome Database (RGD) (myocardial ischemia related genes).
  • Protein-protein interaction (PPI) data: HPRD and BioGRID databases.
  • Gene expression data: Microarray experiments performed on rat models of AMI.

No new benchmarks were introduced; rather, existing databases were integrated to construct the AMI-ODN.

Key Insights and Ideas

  • Network-based approach for TCM: The study successfully demonstrates the power of network pharmacology in dissecting the complex mechanisms of TCM, moving beyond traditional phenotype-based evaluations.
  • Quantifying synergistic effects: The NRI-ODN provides a quantitative measure of a drug's ability to restore a disturbed biological network, allowing for a direct comparison of the efficacy of the whole formula versus its individual components.
  • Validation of "Jun-Chen-Zuo-Shi" rule: The findings strongly support the "Jun-Chen-Zuo-Shi" principle, showing that the "sovereign" (Astragalus) and "minister" (Salvia) herbs contribute more significantly to network recovery than the "assistant" (Notoginseng) and "courier" (Dalbergia) herbs.
  • Distinct roles of herbs: Pathway enrichment analysis revealed that while some pathways are commonly targeted by all components, others are uniquely influenced by specific herbs, suggesting specialized roles. For instance, Astragalus appears to play a role in energy metabolism and blood flow regulation, while Salvia is implicated in apoptosis and inflammation.

Key Results

  • Overall Efficacy: The QSYQ formula achieved a significantly higher NRI-ODN score (864.48) compared to any of its individual component herbs.
  • Component Herb Efficacy: Among the component herbs, Salvia (734.31) and Astragalus (680.27) demonstrated superior network recovery abilities compared to Notoginseng (545.76) and Dalbergia (584.88).
  • Statistical Significance: Astragalus and Salvia showed highly significant recovery effects (P < 0.01), Dalbergia showed significant recovery (P < 0.05), while Notoginseng's effect was not statistically significant (P = 0.18) based on permutation tests.
  • Pathway Overlap: While QSYQ and its components share enrichment in pathways like complement and coagulation cascades, cytokine-cytokine receptor interaction, and MAPK signaling, QSYQ also uniquely enriched pathways related to cell adhesion molecules and regulation of actin cytoskeleton, suggesting novel synergistic effects.

Limitations and Future Work

  • Limitations: The study acknowledges that the topology and efficiency of recovery regulation were not fully considered in the initial NRI-ODN calculation, though a refined version was introduced. The performance of ODN modeling might be limited for orphan diseases.
  • Future Work: The authors suggest that this network-based approach is suitable for studying complex diseases and can be extended to discover similarities and differences between TCM and chemical drugs. Further investigation into the specific molecular targets and interactions within the enriched pathways could provide deeper mechanistic insights. The study also implies that further exploration of the unique pathways enriched by QSYQ could reveal novel therapeutic mechanisms.

Summary updated

Abstract

AMI-ODN model and NRI-ODN identified the possible roles of "Jun-Chen-Zuo-Shi" component herbs of QSYQ in treating AMI at molecular network and pathway level.
BibTeX
@inproceedings{wu2014identifying,
  author = {Leihong Wu and Yi Wang and Zheng Li and Boli Zhang and Yiyu Cheng and Xiaohui Fan},
  title = {{Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology}},
  booktitle = {Chinese},
  year = {2014},
  doi = {10.1186/1749-8546-9-24},
}
Figure